New IDIX info that hasn’t been reported anywhere, to my knowledge: A few days ago, GSK (d/b/a ViiV Healthcare) started a drug-drug-interaction study of IDX899 and MRK’s Isentress (note that GSK2248761 is another name for IDX899):
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.